01/23/2017 - 12:40pm

The campaign is aimed at highlighting those in the industry driving innovation and pointing to the opportunity that exists in tackling complex health conditions. 

01/20/2017 - 3:28pm
The Food and Drug Administration approved the regimen of Opdivo and Yervoy as a treatment for metastatic melanoma in October 2015. 
01/20/2017 - 1:24pm

The drug is indicated to treat adults with chronic idiopathic constipation.

01/19/2017 - 1:52pm
The cream is indicated to treat persistent facial redness from rosacea in adults. 
01/19/2017 - 1:41pm

Alongside the availability announcement, kaléo unveiled its Auvi-Q access program, AffordAbility, through which patients with commercial insurance will have an out-of-pocket cost of $0. 

01/18/2017 - 1:08pm

The study found that retrospective rebates, discounts and fees have increased from $67 billion in 2013 to $106 billion in 2015. 

01/18/2017 - 12:10pm

The drug, indicated for pain severe enough to require daily, around-the-clock, long-term opioid treatment and patients for whom alternative therapy is inadequate, is formulated with Teva’s proprietary abuse-deterrent technology. 

01/18/2017 - 11:52am

The $960 million all-cash transaction is aimed at growing Lilly’s migraine pain management portfolio and will add a potential near-term launch to its late-stage pipeline. 

01/17/2017 - 12:02pm

Carsten Brun will oversee the company’s pharmaceutical arm in the United States, Canada, Central and Latin America, reporting to pharmaceutical division president and board of management member Dieter Weinand.